Invasive Assessment of Right Ventricular to Pulmonary Artery Coupling Improves 1-year Mortality Prediction After Transcatheter Aortic Valve Replacement and Anticipates the Persistence of Extra-Aortic Valve Cardiac Damage.

Aortic stenosis Right ventricular to pulmonary artery coupling Transcatheter aortic valve replacement

Journal

Structural heart : the journal of the Heart Team
ISSN: 2474-8714
Titre abrégé: Struct Heart
Pays: United States
ID NLM: 101743256

Informations de publication

Date de publication:
May 2024
Historique:
received: 19 10 2023
revised: 04 12 2023
accepted: 03 01 2024
medline: 27 5 2024
pubmed: 27 5 2024
entrez: 27 5 2024
Statut: epublish

Résumé

The interplay between the right ventricle and the pulmonary artery, known as right ventricular to pulmonary artery (RV-PA) coupling, is crucial for assessing right ventricular systolic function against the afterload from the pulmonary circulation. Pulmonary artery pressure levels are ideally measured by right heart catheterization. Yet, echocardiography represents the most utilized method for evaluating pulmonary artery pressure levels, albeit with limitations in accuracy. This study therefore aims to evaluate the prognostic significance of right ventricular to pulmonary artery (RV-PA) coupling expressed as tricuspid annular plane systolic excursion (TAPSE) related to systolic pulmonary artery pressure (sPAP) levels measured by right heart catheterization (TAPSE/sPAP Using data from a bicentric registry, this study compares TAPSE/sPAP Among 333 patients with complete echocardiography and right heart catheterization data obtained before TAVR, their mean age was 79.8 ± 6.74 years, 39.6% were female, and general 1-year survival was 89.8%. sPAP RV-PA coupling expressed as TAPSE/sPAP

Sections du résumé

Background UNASSIGNED
The interplay between the right ventricle and the pulmonary artery, known as right ventricular to pulmonary artery (RV-PA) coupling, is crucial for assessing right ventricular systolic function against the afterload from the pulmonary circulation. Pulmonary artery pressure levels are ideally measured by right heart catheterization. Yet, echocardiography represents the most utilized method for evaluating pulmonary artery pressure levels, albeit with limitations in accuracy. This study therefore aims to evaluate the prognostic significance of right ventricular to pulmonary artery (RV-PA) coupling expressed as tricuspid annular plane systolic excursion (TAPSE) related to systolic pulmonary artery pressure (sPAP) levels measured by right heart catheterization (TAPSE/sPAP
Methods UNASSIGNED
Using data from a bicentric registry, this study compares TAPSE/sPAP
Results UNASSIGNED
Among 333 patients with complete echocardiography and right heart catheterization data obtained before TAVR, their mean age was 79.8 ± 6.74 years, 39.6% were female, and general 1-year survival was 89.8%. sPAP
Conclusions UNASSIGNED
RV-PA coupling expressed as TAPSE/sPAP

Identifiants

pubmed: 38799808
doi: 10.1016/j.shj.2024.100282
pii: S2474-8706(24)00003-4
pmc: PMC11121747
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100282

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors report no conflict of interest.

Auteurs

Mark Lachmann (M)

First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Amelie Hesse (A)

First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Teresa Trenkwalder (T)

DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany.

Erion Xhepa (E)

DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany.

Tobias Rheude (T)

Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany.

Moritz von Scheidt (M)

DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany.

Héctor Alfonso Alvarez Covarrubias (HAA)

Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany.

Elena Rippen (E)

First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Oksana Hramiak (O)

First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Specialized Department of Cardiology, Ternopil City Communal Hospital №2, Ternopil National Medical University, Ternopil, Ukraine.

Costanza Pellegrini (C)

Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany.

Tibor Schuster (T)

Department of Family Medicine, McGill University, Montreal, Canada.

Shinsuke Yuasa (S)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Heribert Schunkert (H)

DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany.

Adnan Kastrati (A)

DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany.

Christian Kupatt (C)

First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Karl-Ludwig Laugwitz (KL)

First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Michael Joner (M)

DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany.

Classifications MeSH